Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MTL Cannabis ( (TSE:MTLC) ) just unveiled an update.
MTL Cannabis Corp. has announced the launch of its premium branded cannabis products into the Australian medical market, marking a significant milestone in its international growth strategy. This expansion is expected to capitalize on the rapidly growing Australian medical cannabis market, which is projected to double in revenue by 2028, potentially enhancing MTL’s market positioning and offering new opportunities for stakeholders.
More about MTL Cannabis
MTL Cannabis Corp. is a prominent player in the cannabis industry, operating through its subsidiaries, including Montréal Medical Cannabis Inc., Abba Medix Corp., IsoCanMed Inc., and Canada House Clinics Inc. The company is known for its craft quality cannabis products, utilizing proprietary hydroponic growing methodologies. It offers a range of products such as dried flower, pre-rolls, and hash under various brands for the Canadian market and has developed export channels for bulk cannabis.
Average Trading Volume: 32,798
Technical Sentiment Signal: Buy
Current Market Cap: C$74.88M
For an in-depth examination of MTLC stock, go to TipRanks’ Overview page.